Literature DB >> 885419

The effect of 5,5-diethylbarbituric acid on the biosynthesis of anthracyclines in Streptomyces galilaeus.

E Královcová, M Blumauerová, Z Vanĕk.   

Abstract

5,5-Diethylbarbituric acid (barbital) stimulates the production of anthracycline antibiotics called galirubins in Streptomyces galilaeus in dependence on the strain, concentration and cultivation conditions. The stimulation is more pronounced (up to 300%) in the low-producing strain than in the production mutant. Under conditions of limited aeration the effect of barbital is increased in both strains. In the production strain barbital narrows the spectrum of metabolites produced. Higher barbital concentrations inhibit growth of the mycelium of both strains and decrease the formation of free anthracyclinones.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885419     DOI: 10.1007/bf02885599

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  11 in total

1.  Relation of barbiturate structure to DPNH oxidase inhibition.

Authors:  M L COWGER; R F LABBE; B MACKLER
Journal:  Arch Biochem Biophys       Date:  1962-03       Impact factor: 4.013

2.  Stimulation of streptomycin production by a series of synthetic organic compounds.

Authors:  J H FERGUSON; H T HUANG; J W DAVISSON
Journal:  Appl Microbiol       Date:  1957-09

3.  Useful criteria for species differentiation in the genus Streptomyces.

Authors:  C W HESSELTINE; R G BENEDICT; T G PRIDHAM
Journal:  Ann N Y Acad Sci       Date:  1954-10-29       Impact factor: 5.691

4.  On the effect of barbital on Streptomyces mediterranei.

Authors:  Z Ruczaj; B Ostrowska-Krysiak; D Sawnor-Korszyńska; K Raczyńska-Bojanowska
Journal:  Acta Microbiol Pol B       Date:  1972

5.  [On the identification of a series of anthracycline pigments from Streptomyces galilaeus Stamm JA 3043 (galirubine and galirubinone)].

Authors:  K Eckardt
Journal:  Chem Ber       Date:  1967

6.  [Production of glycosides of epsilon pyrromycinons (galirubine) during the cultivation of Streptomyces galilaeus].

Authors:  E Královcová; J Tax; M Blumauerová; Z Vanĕk
Journal:  Z Allg Mikrobiol       Date:  1977

7.  Hydroxylations of bile acids by reconstituted systems from rat liver microsomes.

Authors:  I Björkhem; H Danielsson; K Wikvall
Journal:  J Biol Chem       Date:  1974-10-25       Impact factor: 5.157

8.  Rifomycin. XIV. Production of rifomycin B.

Authors:  P MARGALITH; H PAGANI
Journal:  Appl Microbiol       Date:  1961-07

9.  [On the characterization of the Streptomyces strain JA 3043 and the production of galirubin and galirubinone].

Authors:  G Bradler; K Eckardt; R Fügner
Journal:  Z Allg Mikrobiol       Date:  1966

10.  FURTHER STUDIES ON THE INDUCTION OF THE DRUG-HYDROXYLATING ENZYME SYSTEM OF LIVER MICROSOMES.

Authors:  S Orrenius
Journal:  J Cell Biol       Date:  1965-09-01       Impact factor: 10.539

View more
  5 in total

1.  Studies on the production of daunomycinone-derived glycosides and related metabolites in Streptomyces coeruleorubidus and Streptomyces peucetius.

Authors:  M Blumauerová; J Matĕjů; K Stajner; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1977       Impact factor: 2.099

2.  Growth and production of anthracyclines in wild-type and mutant strains of Streptomyces galilaeus.

Authors:  E Královcová; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

Review 3.  Control of antibiotic biosynthesis.

Authors:  J F Martin; A L Demain
Journal:  Microbiol Rev       Date:  1980-06

4.  Strain improvement in Streptomyces galilaeus, a producer of anthracycline antibiotics galirubins.

Authors:  E Královocová; M Blumauerová; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1977       Impact factor: 2.099

5.  Mutants of Streptomyces coeruleorubidus impaired in the biosynthesis of daunomycinone glycosides and related metabolites.

Authors:  M Blumauerová; K Stajner; V Pokorný; Z Hostálek; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1978       Impact factor: 2.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.